US Stem Cell Inc (USRM)

[Dragon Lady]

Hello Bioheart Inc,

Since you are the official corp representative on this msg board (per your own commentary that you validated that you are thee real company, thee real spokesperson here on I-HUB for Bioheart, now known as U.S. Stem Cell Inc, and got the "corporate validation" symbol in your profile)

Can you please reply to us and confirm that all the following items are indeed 100% true and accurate, correct and validated by "SHE" and the "CEO" who apparently had a "meeting" at your company headquarters recently, this past Thurs and Fri March 2nd and 3rd where numerous items were discussed, and much information was disclosed to a common shareholder.

Would be greatly appreciated. Look forward to your official corporate response, again, since you stated you are here to monitor the board, answer any and all questions as the official corp spokesperson etc.

We just really, really wanna "get this on the record" from you, the corporation, for numerous reasons. Again, thanks in advance:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129202448

Again, just validate it all as correct and confirmed please:

"USRM MEETING AND UPDATE(OFFICIAL):

I went to the company and took some pictures which will be posted on my twitter. I do not know how to upload them on here after 5 years. The building is super nice and although I got pictures, we were not allowed to take pics inside of the lab. It is against FDA regulations. Here are the points of what we discussed and small explanations of them:


*This month: the results of their clinical trials are due after all these years. They WILL give an update out sometime in 2-3 weeks she said. She was a very nice lady. So for anyone trying to say nothing is coming, rs, dilution etc, I can dispel all that right now.

*She said she was EXCEEDINGLY excited about the way the trial is going and has a vested interest with stock options to buy shares and is well aware of the share price. She is confident that they will pass this trial but she cannot say anything with 100% because that would be insider trading rules/guidelines etc. But she said the confidence levels are high.

*Cures Act: Applied under the Cures Act and their product falls under the RAT protocols undeniably! Meaning if this endpoint does well, they can skip steps.

* The results of passing: Once the pivotal trial is completed, they can skip the next study trials/endpoints and GO STRAIGHT TO COMMERCIALIZATION!!!! We will be the FRIST cardio stem cell RAT drug to market...."billion dollar opportunity". Ceo said this.

*Company/Employees Hiring: They have 22 people in the office working(that is a lot folks) and have another building not too far away for the other part of the business. They are hiring a dozen or more employees for various vacancies.

*Buyout: Yes. She was not in charge of certain matters but did refer me back to the pacer filings when I asked about it. But it is true. They got MULTIPLE OFFERS. The price was unbeknownst to her but again, refer to pacer. There will be filings this month about the phase results. My guess is guys, the better the data, the more its worth. Simple.

*Pictures: Please go to my twitter to see them. Feel free to copy and post them. https://twitter.com/OCMillionaire
"

Thanks again Bioheart/U.S. Stem Cell, Inc. Great for you to be here for us to answer our questions.